Prevent Blindness is partnering with an organization called Medscape Education to recruit 4 individuals with wet AMD who are receiving anti-VEGF injections to participate in an online focus group on Monday, January 26th at 7-9:30p ET. Goal of the focus group These discussions are an essential first step in addressing a well-documented gap in [Read More]
Category: Latest News
PRIMA System Improves Sight in Individuals With Geographic Atrophy
A study involving participants with geographic atrophy due to dry AMD, has shown that a photovoltaic subretinal implant, combined with glasses that project near-infrared light to the implant, has led to significant improvement in visual acuity in 32 participants. This so-called PRIMA system represents the first eye prosthesis to restore functional sight in people with [Read More]
Geographic Atrophy: Knowledge, Hope, and Help
Are you living with geographic atrophy or have a family member who has been diagnosed with geographic atrophy? If so, please join Prevent Blindness for this 60-minute community forum on Tuesday, October 28th from 7:00-8:00pm Eastern to: Learn about geographic atrophy - what it is, how it is diagnosed, and how it is managed Understand [Read More]
Important Accessibility Bill Seeking Congressional Support
The American Council of the Blind (ACB) has announced that the Website and Software Applications Accessibility Act has once again been introduced in the House of Representatives on Wednesday, May 14. This was a wonderful way to usher in Global Accessibility Awareness Day (GAAD) on Thursday, May 15. The bill was introduced by Republican Congressman [Read More]
New Drug Approved for Treatment of Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. has announced FDA approval of ENCELTO (revakinagene taroretcel-lwey) for the treatment of Macular Telangiectasia type 2 (MacTel). ENCELTO is the First and Only FDA-approved first and only treatment for MacTel. MacTel is a neurodegenerative disease of the retina in adults that causes progressive and irreversible vision loss, significantly impacting patients’ quality of [Read More]